| Financial Year |
March 31 2023 |
| Monetary Funds |
391,957,692.53 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
168,438,472.56 |
| Advances to Suppliers |
49,198,037.75 |
| Other Receivables |
10,484,882.76 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
262,238,899.19 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,942,510.54 |
| Total Current Assets |
980,838,575.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
33,864,153.83 |
| Investment Properties |
-- |
| Fixed Assetes |
915,499,752.26 |
| Under-construction Projects |
292,585,714.90 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
149,540,517.79 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
719,137.24 |
| Deferred Income Tax Assets |
27,244,800.51 |
| Other Non-Current Assets |
47,898,371.57 |
| Sub-Total of Non-Current Assets |
1,478,713,003.29 |
| Total Assets |
2,459,551,578.44 |
| Short-Term Loans |
269,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,300,000.00 |
| Accounts Payable |
93,877,311.68 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,378,995.14 |
| Taxes Payable |
9,383,422.36 |
| Interest Payable |
-- |
| Dividend Payable |
3,767,826.90 |
| Other payables |
84,999,380.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
279,704,994.22 |
| Other Current Liabilities |
846,744.55 |
| Sub-Total of Current Liabilities |
767,897,890.29 |
| Long-term Loans |
109,450,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
111,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
335,026.85 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
241,285,695.96 |
| Total Liabilities |
1,009,183,586.25 |
| Paid-In Capital(Or Share Stock) |
353,973,939.00 |
| Capital Surplus |
395,043,365.24 |
| Surplus Reserve |
149,209,540.72 |
| LESS:Treasury Stock |
36,189,810.00 |
| Undistributed Profits |
600,543,239.78 |
| Minority Stockholder's Interest |
-12,190,254.27 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,462,558,246.46 |
| Owner's Equity（Stockholder's Equity） |
1,450,367,992.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,459,551,578.44 |
